Clinical Focus: Expert Insights on New Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Tumors

Experts discuss advances in the diagnosis, management, and treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) as well as their impact on patient quality of life. Improve your ability to optimally integrate the recommended diagnostic techniques and treatments based on current safety and efficacy data to better care for patients with GEP-NETs.

Share

Program Content

Activities

GEP-NETs:  Podcast
Gastroenteropancreatic Neuroendocrine Tumors: Diagnosis, Findings, and Recommendations
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: October 17, 2024

Expires: October 16, 2025

Faculty

cover img faculity

Thor R. Halfdanarson, MD

Consultant, Division of Medical Oncology
Professor of Oncology
Associate Professor of Medicine
Mayo Clinic Comprehensive Cancer Center
Chair, Hepato-Pancreatico-Biliary Disease Group
Rochester, Minnesota

cover img faculity

Jonathan Strosberg, MD

Professor, GI Oncology
Chair, Neuroendocrine Tumor Division
Moffitt Cancer Center and Research Institute
Tampa, Florida

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation